QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Mr. Douglas Bryant est le President de QuidelOrtho Corp, il a rejoint l'entreprise depuis 2009.
Quelle est la performance du prix de l'action QDEL ?
Le prix actuel de QDEL est de $0, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de QuidelOrtho Corp ?
QuidelOrtho Corp appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de QuidelOrtho Corp ?
La capitalisation boursière actuelle de QuidelOrtho Corp est de $NaN
Est-ce que QuidelOrtho Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 9 analystes ont établi des notations d'analystes pour QuidelOrtho Corp, y compris 4 achat fort, 6 achat, 4 maintien, 1 vente et 4 vente forte